| 44566-8 |
Influenza virus A+B Ag |
PrThr |
Bronchial |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus A+B Ag [Presence] in Bronchial specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44566-8 |
|
|
|
|
Both |
|
|
|
0 |
FLUAV+FLUBV Ag Bronch Ql |
|
|
|
N |
|
A,B; Antigen; Antigens; Avian influenza; Bird flu; Bro; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44567-6 |
Influenza virus A+B Ag |
PrThr |
Nose |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus A+B Ag [Presence] in Nose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44567-6 |
|
|
|
|
Both |
|
|
|
0 |
FLUAV+FLUBV Ag Nose Ql |
|
|
|
N |
|
A,B; Antigen; Antigens; Avian influenza; Bird flu; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44568-4 |
Influenza virus B Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Influenza virus B Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44568-4 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
FLUBV Ab Ser Ql CF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44569-2 |
Influenza virus B Ab |
PrThr |
Body fld |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus B Ab [Presence] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44569-2 |
|
|
|
|
Both |
|
|
|
0 |
FLUBV Ab Fld Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; FLUB; FLUBV; Fluid; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4457-8 |
Tripelennamine |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Tripelennamine [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4457-8 |
|
|
|
|
Observation |
|
|
|
0 |
Tripelennamine Dose |
|
|
|
Y |
|
Dose med or substance; DRUG DOSES; Point in time; Pyribenzamine; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
| 44570-0 |
Influenza virus B Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus B Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44570-0 |
|
|
|
|
Both |
|
|
|
0 |
FLUBV Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44571-8 |
Influenza virus B Ag |
PrThr |
Nph |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus B Ag [Presence] in Nasopharynx by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44571-8 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUBV Ag Nph Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; FLUB; FLUBV; Fluorescent antibody; Fluoresent; FLUV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Nasopharynx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44572-6 |
Influenza virus B Ag |
PrThr |
Bronchial |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus B Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44572-6 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUBV Ag Bronch Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Bro; DFA; FA; FLUB; FLUBV; Fluorescent antibody; Fluoresent; FLUV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44573-4 |
Influenza virus B Ag |
PrThr |
Nose |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus B Ag [Presence] in Nose by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44573-4 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUBV Ag Nose Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; FLUB; FLUBV; Fluorescent antibody; Fluoresent; FLUV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell; Time Resolved Fluorescence; TRF |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44574-2 |
Influenza virus B Ag |
PrThr |
Trac |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus B Ag [Presence] in Trachea by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44574-2 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUBV Ag Trachea Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; FLUB; FLUBV; Fluorescent antibody; Fluoresent; FLUV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Trachea; TRF |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44575-9 |
Influenza virus B Ag |
PrThr |
Nose |
Pt |
Ord |
IA |
|
ACTIVE |
Influenza virus B Ag [Presence] in Nose by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44575-9 |
|
IA |
|
|
Both |
|
|
|
0 |
FLUBV Ag Nose Ql IA |
|
|
|
N |
|
Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell; SUDS |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44576-7 |
Influenza virus B Ag |
PrThr |
Bronchial |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus B Ag [Presence] in Bronchial specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44576-7 |
|
|
|
|
Both |
|
|
|
0 |
FLUBV Ag Bronch Ql |
|
|
|
N |
|
Antigen; Antigens; Bro; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44577-5 |
Influenza virus B Ag |
PrThr |
Nose |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus B Ag [Presence] in Nose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44577-5 |
|
|
|
|
Both |
|
|
|
0 |
FLUBV Ag Nose Ql |
|
|
|
N |
|
Antigen; Antigens; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44578-3 |
Influenza virus C Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Influenza virus C Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44578-3 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
FLUCV Ab Ser Ql CF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; FLUC; FLUCV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza C; Influenza C virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44579-1 |
Influenza virus C Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus C Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44579-1 |
|
|
|
|
Both |
|
|
|
0 |
FLUCV Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; FLUC; FLUCV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza C; Influenza C virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4458-6 |
Valproate |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Valproate [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4458-6 |
|
|
|
|
Observation |
|
|
|
0 |
Valproate Dose |
|
|
|
Y |
|
Depakene; Divalproex; Dose med or substance; DRUG DOSES; Point in time; QNT; Quan; Quant; Quantitative; Random; VALP; Valproic acid |
2.73 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
| 44580-9 |
HTLV I+II p21 env Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
HTLV I+II p21 env Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44580-9 |
|
IB |
|
|
Observation |
|
|
|
0 |
HTLV I+II p21 Env Ab Ser Ql IB |
|
|
|
N |
|
2; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44581-7 |
HTLV I+II p38 tax Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
HTLV I+II p38 tax Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44581-7 |
|
IB |
|
|
Observation |
|
|
|
0 |
HTLV I+II p38 Tax Ab Ser Ql IB |
|
|
|
N |
|
2; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44582-5 |
IgA |
PrThr |
Skin |
Pt |
Ord |
IF |
|
ACTIVE |
IgA [Presence] in Skin by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44582-5 |
|
IF |
|
|
Both |
|
|
|
0 |
IgA Skin Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Chemistry; Dermatologic; Epidermis; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin A; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin A; Integument; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Skn; Time Resolved Fluorescence; TRF |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44583-3 |
IgA Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
HAI |
|
ACTIVE |
IgA Ab [Presence] in Serum or Plasma by Hemagglutination inhibition |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44583-3 |
|
HAI |
|
|
Both |
|
|
|
0 |
IgA Ab SerPl Ql HAI |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chemistry; HEMAGGLUTINATION INHIBITION; HI; Immune globulin A; Immunoglobulin A; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44584-1 |
IgA Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
IgA Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44584-1 |
|
|
|
|
Both |
|
|
|
0 |
IgA Ab SerPl Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chemistry; Immune globulin A; Immunoglobulin A; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44585-8 |
IgA Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
IgA IgG Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44585-8 |
|
|
|
|
Both |
|
|
|
0 |
IgA IgG SerPl Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chemistry; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44586-6 |
IgA Ab.IgM |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
IgA IgM Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44586-6 |
|
|
|
|
Both |
|
|
|
0 |
IgA IgM SerPl Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chemistry; Immune globulin A; Immune globulin M; Immunoglobulin A; Immunoglobulin M; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44587-4 |
IgA.monoclonal |
PrThr |
Ser |
Pt |
Ord |
Immunofixation |
|
ACTIVE |
IgA.monoclonal [Presence] in Serum by Immunofixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44587-4 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
M-IgA Ser Ql IFE |
|
|
|
N |
|
Chemistry; IFE; Ifix; Immune globulin A; Immunofixation electrophoresis; Immunoglobulin A; M-IgA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44588-2 |
IgA.monoclonal |
PrThr |
Urine |
Pt |
Ord |
Immunofixation |
|
ACTIVE |
IgA.monoclonal [Presence] in Urine by Immunofixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44588-2 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
M-IgA Ur Ql IFE |
|
|
|
N |
|
Chemistry; Hematology; Heme; IFE; Ifix; Immune globulin A; Immunofixation electrophoresis; Immunoglobulin A; M-IgA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
